Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 113422713 | 11342271 | 3 | F | 201401 | 20160802 | 20150805 | 20160809 | EXP | DK-DKMA-ADR 23058970 | DK-UCBSA-2015024379 | UCB | 41.66 | YR | F | Y | 0.00000 | 20160809 | MD | DK | DK |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 113422713 | 11342271 | 1 | PS | CIMZIA | CERTOLIZUMAB PEGOL | 1 | Subcutaneous | 400 MG, EV 2 WEEKS(QOW) | Y | U | 125160 | 400 | MG | SOLUTION FOR INJECTION | QOW | ||||
| 113422713 | 11342271 | 2 | C | METHOTREXATE. | METHOTREXATE | 1 | UNK | U | 0 | ||||||||||
| 113422713 | 11342271 | 3 | C | METHOTREXATE. | METHOTREXATE | 1 | 10 MG, WEEKLY (QW) | U | 0 | 10 | MG | /wk | |||||||
| 113422713 | 11342271 | 4 | C | METHOTREXATE. | METHOTREXATE | 1 | Oral | UNK | U | 0 | |||||||||
| 113422713 | 11342271 | 5 | C | FOLIC ACID. | FOLIC ACID | 1 | 5 MG, ONCE DAILY (QD) | U | 0 | 5 | MG | TABLET | QD | ||||||
| 113422713 | 11342271 | 6 | C | Dermovat | CLOBETASOL | 1 | UNK | U | 0 | ||||||||||
| 113422713 | 11342271 | 7 | C | Dicillin | DICLOXACILLIN SODIUM | 1 | UNK | U | 0 | ||||||||||
| 113422713 | 11342271 | 8 | C | Potassium permanganate | POTASSIUM PERMANGANATE | 1 | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 113422713 | 11342271 | 1 | Rheumatoid arthritis |
| 113422713 | 11342271 | 2 | Product used for unknown indication |
| 113422713 | 11342271 | 5 | Rheumatoid arthritis |
| 113422713 | 11342271 | 6 | Product used for unknown indication |
| 113422713 | 11342271 | 7 | Product used for unknown indication |
| 113422713 | 11342271 | 8 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 113422713 | 11342271 | DS |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 113422713 | 11342271 | Alopecia | |
| 113422713 | 11342271 | Drug eruption | |
| 113422713 | 11342271 | Pain | |
| 113422713 | 11342271 | Pruritus | |
| 113422713 | 11342271 | Rash |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 113422713 | 11342271 | 1 | 20121214 | 20140103 | 0 | |
| 113422713 | 11342271 | 2 | 20100930 | 20120626 | 0 | |
| 113422713 | 11342271 | 3 | 20121123 | 0 | ||
| 113422713 | 11342271 | 4 | 20140613 | 0 | ||
| 113422713 | 11342271 | 5 | 20121123 | 0 |